Skip to main content

Table 2 Ovarian stimulation data

From: What is the impact of endometriosis and the AFS stage on cumulative pregnancy rates in IVF programs?

 

Group A

Group B

Group C

Group D

Group E

p

N cycles

430

460

56

88

316

 

IVF and ICSI (%)

30.2/69.8

45.2/54.8

25.2/74.8

52.2/47.8

46.8/53.2

***A–B, A–D, B–C, C–D, C–E

Cycle rank (n)

1.6 ± 0.9

1.6 ± 0.9

1.6 ± 0.9

1.5 ± 0.9

1.6 ± 0.9

 

Antagonist (%)

86.9

83.0

85.7

84.0

82.2

 

Short agonist (%)

3.7

6.9

10.7

6.8

6.3

*B–C, C–D; **A–D, C–E; ***A–B, A–C

Long agonist (%)

9.4

10.1

3.6

9.2

11.5

***A–C, B–C, C–D, C–E

Initial FSH dose (IU/day)

272 ± 111

303 ± 123

272 ± 132

327 ± 114

303 ± 116

*C–D; ***A–B

Total FSH dose (IU)

2688 ± 1011

3059 ± 1506

2795 ± 1546

3329 ± 1344

3032 ± 1327

*C–D; ***A–B

E2 on dhCG (pg/mL)

2108 ± 1248

1916 ± 1173

2272 ± 754

1703 ± 1162

1913 ± 1229

*A–B, A–E; **A–D, B–C, C–E; ***C–D

LH on dhCG (IU/L)

3.3 ± 2.3

2.7 ± 2.1

2.0 ± 1.2

2.8 ± 2.2

2.8 ± 2.1

**A–E, C–D; ***A–B, A–C, B–C, C–E

P on dhCG (ng/mL)

0.9 ± 0.4

0.9 ± 0.4

0.8 ± 0.1

1.0 ± 0.2

0.9 ± 0.3

 

Endometrium thickness (mm)

9.6 ± 2.0

9.6 ± 1.9

10.5 ± 1.7

9.7 ± 1.3

9.5 ± 2.3

**C–D; ***A–C, B–C, CE

Sperm count (Ă—106/mL)

36.4 ± 27.1

54.6 ± 42.5

36.6 ± 21.7

93.0 ± 44.0

46.3 ± 29.8

**B–E, C–E; ***A–B, A–D, B–C, B–D, C–D, D–E

  1. Group A: women without endometriosis; group B: women with endometriosis (all stages); group C: women with stage 1/2 endometriosis; group D: women with stage 3/4 endometriosis (without endometrioma); group E: women with endometrioma alone
  2. dhCG hCG trigger day
  3. Statistical significance: *p < 0.05; **p < 0.01; ***p < 0.001. The other comparisons were not significant